Evaluation of humoral and cellular response to third dose of BNT162b2 mRNA COVID-19 vaccine in patients treated with B-cell depleting therapy()

OBJECTIVE: to investigate the responses to mRNA COVID-19 vaccines in a cohort of immunosuppressed patients affected by immune-mediated inflammatory diseases (IMID). METHODS: we have measured humoral and cellular immunity using quantitative IgG anti-SARS-CoV-2 Spike antibody (anti-S-IgG), neutralizat...

Descripción completa

Detalles Bibliográficos
Autores principales: Firinu, Davide, Fenu, Giuseppe, Sanna, Giuseppina, Costanzo, Giulia A., Perra, Andrea, Campagna, Marcello, Littera, Roberto, Locci, Carlotta, Marongiu, Alessandra, Cappai, Riccardo, Melis, Maurizio, Orrù, Germano, Del Giacco, Stefano, Coghe, Ferdinando, Manzin, Aldo, Chessa, Luchino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189114/
https://www.ncbi.nlm.nih.gov/pubmed/35714496
http://dx.doi.org/10.1016/j.jaut.2022.102848

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189114/
https://www.ncbi.nlm.nih.gov/pubmed/35714496
http://dx.doi.org/10.1016/j.jaut.2022.102848

Ejemplares similares